Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Stephen E. Fremes"'
Autor:
Jae K. Oh, G. Michael Deeb, G. Chad Hughes, Steven J. Yakubov, Stephen E. Fremes, Michael J. Reardon, Thomas G. Gleason, Stuart J. Head, Thomas Modine, Jian Huang, J. Kevin Harrison, M. Erwin Tan, Ka Yan Lam, Pim A.L. Tonino
Publikováno v:
The Annals of Thoracic Surgery. 113:616-622
Randomized clinical trials have shown that transcatheter aortic valve replacement is noninferior to surgery in low surgical risk patients. We compared outcomes in patients treated with a sutured (stented or stentless) or sutureless surgical valve fro
Autor:
Joanna Chikwe, Harindra C. Wijeysundera, Paymon M. Azizi, Derrick Y. Tam, Mario Gaudino, Stephen E. Fremes
Publikováno v:
European Heart Journal - Quality of Care and Clinical Outcomes. 7:556-563
Aims The economic value of transcatheter aortic valve replacement (TAVR) in low surgical risk patients with severe, symptomatic aortic stenosis is not known. Our objective was to determine the cost-effectiveness of balloon-expandable TAVR and self-ex
Publikováno v:
The Annals of thoracic surgery. 106(3)
Background A recent clinical trial showed that self-expandable transcatheter aortic valve replacement (TAVR) was non-inferior to surgical aortic valve replacement (SAVR). However, the cost-effectiveness of self-expandable TAVR in the intermediate-ris
Autor:
Harindra C. Wijeysundera, Derrick Y. Tam, Rebecca Hancock-Howard, Stephen E. Fremes, Peter C. Coyte, Avery Hughes, Saerom Youn
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 155(5)
Objective Although transcatheter aortic valve implantation has been shown to be noninferior to surgical aortic valve replacement in patients with severe aortic stenosis at intermediate surgical risk, the cost-effectiveness of this strategy in this po
Autor:
Samuel V. Lichtenstein, Josep Rodés-Cabau, Philippe Pibarot, Reda Ibrahim, John G. Webb, Stephen E. Fremes, Christopher M. Feindel, Robert C. Welsh, Marc Ruel
Publikováno v:
The Canadian journal of cardiology. 28(5)
Patients with severe symptomatic aortic stenosis have a poor prognosis with medical management alone, and balloon aortic valvuloplasty has failed to provide durable clinical benefit. Open surgical replacement of the aortic valve can improve symptoms